PO-0730: Urinary and erectile function in prostate cancer patients: radical radiotherapy vs active surveillance  by Alvisi, M.F. et al.
3rd ESTRO Forum 2015                                                                                                                                         S361 
 
we detected a significant correlation between an elevated 
NLR with decreased DMFS in univariate (HR 1.95, 95% CI 1.07-
3.54, p=0.029) and in multivariate analysis (HR 2.79, 95% CI 
1.49- 5.19, p=0.001). In OS analysis, the elevated NLR was 
significantly associated with decreased OS in univariate 
analysis (HR 1.79, 95% CI1.04-3.04, p=0.036) and multivariate 
analysis (HR 1.98, 95% CI 1.13-3.47, p=0.018).  
Conclusions: The NLR seems to represent an independent 
prognostic marker and should be considered for future 
individual risk assessment in patients with prostate cancer.  
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Purpose/Objective: International Prostate Symptoms Score 
(IPSS) and International Index Erectile Function (IIEF-5) were 
assessed in prostate cancer (PCa) patients (pts). We here 
compare IPSS/IIEF in active surveillance (AS) vs radical 
radiotherapy (RT). 
Materials and Methods: Questionnaires filled in at 4 followup 
(fup) times: T0=enrollment in AS/RT; T1=10 mos after 
diagnosis (fairly corresponding to 3 mos from RT end); T2=12 
mos from diagnosis/6 mos from RT and T3= 24 mos from 
diagnosis/18 mos from RT. RT population also had 
measurement at RT end.  
In the RT population the subset of pts without androgen 
deprivation (AD) was selected for IIEF analysis. 
IPSS was divided into 3 classes: =0-7 (mild symptoms, symp), 
8-19 (moderate symp), 20-35 (severe symp). IIEF was 
separated into 3 levels: 22-25 (no erectile dysfunction, ED), 
12-21 (mild/moderate ED), 0-11 (severe ED). 
Significant changes over time were investigated with Z-test 
for proportions. 
Results: Cohorts: 247 pts (AS), 494 pts (RT IPSS), 202 pts (RT 
no AD). Median age: 64 (AS) vs 72 (RT) yrs. 
IPSS significantly greater in high prostate volumes (>65cc, 
p=0.007), IIEF declines with age (continuous, p=0.001). 
IPSS changes by baseline class stratification (fig 1a-1b): 
different behavior for AS vs RT in no and mild symp class: AS 
pts show a slight worsening with time (ageing?) while RT pts 
show a marked worsening at RT end, which is then recovered 
till AS levels are reached. Notably, pts with severe symp at 
baseline display partial resolution of their symp in both 
cohorts, probably due to prescription of drug for benign 
prostatic hyperplasia in AS and AD in RT.  
Mean IIEF stratified by basal class+age (fig 1c-1d): youngest 
pts without ED show substantial worsening in RT, which was 
persistent with time. Corresponding AS pts reported just 
small declining. Older pts: effect of ageing more evident in 
AS, with substantial decline over time. RT pts show combined 
effect of ageing+RT, with worsening without recover. Ageing 
effect less evident in pts with mild baseline ED: here decline 
at time of rebiopsy (in AS) but then initial levels recovered. 
Worsening in RT seems here entirely due to RT (younger pts 
exhibiting greater decline). 
Significant decline in IIEF, defined as severe ED in pts with 
IIEF-5>11 at T0, was always significantly higher in RT, about 
13% vs 40% (p<0.05). 
 
 
 
Conclusions: IPSS showed a significant worsening in RT at 
short fup (acute phase of radioinduced toxicity). Due to the 
timing of onset of late urinary toxicity, these results (limited 
to 18 mos fup) cannot be considered conclusive for this 
endpoint.  
Greater worsening of ED in RT, especially when younger pts 
are considered. For older pts effect of ageing sums up with 
dose, especially for initially potent pts.  
Comparison between AS and RT allows evaluation of 
confounding factors (ageing, psychological aspects) when 
studying ED after RT, thus allowing a more confident 
estimation of the role of RT in the onset of this kind of 
morbidity.  
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